SJS Investment Consulting’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1K Buy
191
+171
+855% +$1.06K ﹤0.01% 2495
2026
Q2
$124 Buy
+20
New +$110 ﹤0.01% 2566

Other funds holding ABEO

SJS Investment Consulting's ABEO Position: Q3 2026 in Review

SJS Investment Consulting increased its Abeona Therapeutics (ABEO) stake by 855% in Q3 2026, buying an estimated $1.06K and bringing the position to 191 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2495.

SJS Investment Consulting first reported a position in ABEO in Q2 2026 and has held it in 2 quarters since. 114 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • SJS Investment Consulting held 191 shares of Abeona Therapeutics worth $1K as of Q3 2026.
  • SJS Investment Consulting bought 171 Abeona Therapeutics shares in Q3 2026, an estimated $1.06K.
  • Abeona Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2495 holding.
  • SJS Investment Consulting first reported a position in Abeona Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 114 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.